Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Engedi 1000

Next Previous
Drug Profile

Engedi 1000

Alternative Names: E 1K; Engedi1000

Latest Information Update: 28 Jan 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ensol Biosciences
  • Class Analgesics; Antirheumatics; Peptides
  • Mechanism of Action Nerve growth factor inhibitors; Smad protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Osteoarthritis

Most Recent Events

  • 29 Nov 2023 Ensol Bioscience completes a phase II trial in Osteoarthritis (In adults, In the elderly) in South Korea (Intra-articular, Injection) (NCT05697952)
  • 07 Sep 2022 Engedi 1000 is still in phase-I development in Osteoarthritis in South Korea (Intra-articular, Injection) (Ensol Biosciences pipeline, September 2022)
  • 07 Sep 2022 Phase-II clinical trials in Osteoarthritis (In adults, In the elderly) in South Korea (Intra-articular, Injection) (NCT05697952) (Ensol Biosciences pipeline, September 2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top